This is the second time a new Alzheimer's treatment has been rejected by the health spending watchdog in a matter of months.

Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.

Dementia Australia, the national peak body that supports people living with dementia, said it is "disappointed" after the ...

Credit: Getty Images As lecanemab becomes more commonly used, its effect on cardiovascular health should be analyzed. The US Food and Drug Administration’s 2023 approval of the anti-amyloid ...

A couple from Hull have called on the government to fund new Alzheimer's drugs, even though they say it will come "too late" ...

Donanemab is a targeted antibody drug which slows down the early stages of Alzheimer’s. The drug, and another new drug for Alzheimer’s called lecanemab, have been billed as a huge step forward in ...

A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending watchdog said it “does not currently demonstrate value for the NHS”. The news ...

Credit: Getty Images As lecanemab becomes more commonly used, its effect on cardiovascular health should be analyzed. The US Food and Drug Administration’s 2023 approval of the anti-amyloid monoclonal ...

Many dementia cases could be prevented, but far from all: study Millions of cases of dementia could be prevented or delayed by reducing a range of risk factors such as smoking or air pollution, ...

Broadcaster Sally Magnusson faces the dilemma of whether to take part in research that could indicate if she is likely to ...